Get the Stockscreener App
1.28
2.29%
-0.03
After Hours:
1.28
Cerus Corp stock is traded at $1.28, with a volume of 1.25M.
It is down -2.29% in the last 24 hours and down -9.22% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
See More
Previous Close:
$1.31
Open:
$1.3
24h Volume:
1.25M
Relative Volume:
1.10
Market Cap:
$244.69M
Revenue:
$156.37M
Net Income/Loss:
$-37.49M
P/E Ratio:
-6.0952
EPS:
-0.21
Net Cash Flow:
$-47.77M
1W Performance:
-5.88%
1M Performance:
-9.22%
6M Performance:
-31.55%
1Y Performance:
-43.36%
1-Day Range:
$1.2713
$1.325
1-Week Range:
$1.2713
$1.41
52-Week Range:
$1.12
$2.54
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.28 | 250.42M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-24 | Initiated | Craig Hallum | Buy |
| Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-08-20 | Resumed | BTIG Research | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| Feb-26-20 | Initiated | BTIG Research | Buy |
| Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-28-19 | Initiated | Stifel | Buy |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-08-17 | Resumed | BTIG Research | Neutral |
| Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
| Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
| May-02-14 | Reiterated | MLV & Co | Buy |
| Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-15-13 | Reiterated | MLV & Co | Buy |
| Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
| Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-10-11 | Reiterated | MLV & Co | Buy |
| Jun-03-11 | Initiated | Wedbush | Outperform |
| Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
When is Cerus Corporation stock expected to show significant growthRetirement Planning Forecasts For Consistent Profits - jammulinksnews.com
Why Cerus Corporation stock attracts strong analyst attentionFree High Accuracy Alerts for ROI Traders - Newser
Using R and stats models for Cerus Corporation forecastingTechnical Entry Plan with Risk Minimization - Newser
Is it time to cut losses on Cerus CorporationSwing Trading Plan With Smart Signals in Review - metal.it
Understanding Cerus Corporation’s price movementPortfolio Allocation Strategy for Stability - Newser
What makes Cerus Corporation stock price move sharplyReal-Time Investment Picks with Accuracy - Newser
What are analysts’ price targets for Cerus Corporation in the next 12 monthsAI Powered Updates From AI Tools - jammulinksnews.com
Key External Factors That Drive Cerus Corporation Stock Price MovementsFree Stock Market Analysis Courses - Newser
Is Cerus Corporation Stock a Good Fit for Conservative InvestorsDaily Breakout Picks - Newser
Cerus Corporation Stock Analysis and ForecastFree Market Dynamics Reports - PrintWeekIndia
What drives Cerus Corporation stock priceFree Stock Market Mentorship - Autocar Professional
How Cerus Corporation stock performs during market volatilityDouble Profit With Half Risk - Newser
What analysts say about Cerus Corporation stockConsistent triple returns - Autocar Professional
Is Cerus Corporation a good long term investmentSuperior trading gains - jammulinksnews.com
Cerus Earnings: Q2 2025 Results and Investor Call Scheduled for August 5 After Market Close - Stock Titan
Cerus stock rises after securing additional $7.2 million DoD contract By Investing.com - Investing.com Canada
Cerus stock rises after securing additional $7.2 million DoD contract - Investing.com
Cerus receives $7.2 million DoD contract amendment for trauma treatment - Investing.com
Cerus Secures $7.2M DoD Contract to Advance Breakthrough Trauma Treatment Study - Stock Titan
Cerus Q4 2024 slides: Positive EBITDA achieved amid 15% revenue growth - Investing.com Canada
Cerus Q4 2024 slides: Positive EBITDA achieved amid 15% revenue growth By Investing.com - Investing.com South Africa
Cerus Leads The Pack Of 3 Promising Penny Stocks - Yahoo Finance
Cerus advances European regulatory review for INTERCEPT RBC system - Investing.com
Cerus Appoints New Chair Following Board Retirement - TipRanks
Daily Market Movement: Cerus Corp (CERS) Sees a 6.82 Increase, Closing at 1.41 - DWinneX
26,884 Shares in Cerus Co. (NASDAQ:CERS) Purchased by Pallas Capital Advisors LLC - Defense World
Cerus Corporation Celebrates World Blood Donor Day 2025 - Yahoo Finance
Cerus at Goldman Sachs Conference: Pathogen Reduction Leadership - Investing.com
Cerus at Goldman Sachs Conference: Pathogen Reduction Leadership By Investing.com - Investing.com Canada
Cerus Corp shareholders approve equity plan amendment By Investing.com - Investing.com South Africa
Cerus Corp shareholders approve equity plan amendment - Investing.com
Sigyn Therapeutics (OTCMKTS:SIGY) & Cerus (NASDAQ:CERS) Head to Head Comparison - Defense World
Two Sigma Investments LP Acquires 326,605 Shares of Cerus Co. (NASDAQ:CERS) - Defense World
Mackenzie Financial Corp Acquires 17,704 Shares of Seanergy Maritime Holdings Corp. (NASDAQ:SHIP) - Defense World
3 Promising Penny Stocks With Market Caps Over $90M - Yahoo Finance
Cerus Management Takes Stage at Goldman Sachs Healthcare Conference: Key Updates Coming June 11 - Stock Titan
Cantor Fitzgerald maintains Cerus stock rating due to regulatory approvals By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains Cerus stock rating due to regulatory approvals - Investing.com
Cerus to present new INTERCEPT Blood System data at ISBT Congress - Investing.com
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan - Yahoo Finance
Cerus (CERS) Gains French and Swiss Regulatory Approvals for New Device | CERS Stock News - GuruFocus
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):